Prostate cancer cells differ in testosterone accumulation, dihydrotestosterone conversion, and androgen receptor signaling response to steroid 5α‐reductase inhibitors
作者： Yue Wu , Alejandro Godoy , Faris Azzouni , John H. Wilton , Clement Ip
DOI: 10.1002/PROS.22694
关键词: Androgen receptor 、 Dutasteride 、 Medicine 、 Prostate cancer 、 Testosterone 、 Dihydrotestosterone 、 5 Alpha-Reductase Inhibitor 、 Finasteride 、 Internal medicine 、 Endocrinology 、 Androgen
摘要: BACKGROUND Blocking 5α‐reductase‐mediated testosterone conversion to dihydrotestosterone (DHT) with finasteride or dutasteride is the driving hypothesis behind two prostate …
sci-hub.se 参考文章(38)
James L. Mohler, Castration-Recurrent Prostate Cancer Is Not Androgen-Independent Hormonal Carcinogenesis V. ,vol. 617, pp. 223- 234 ,(2008) , 10.1007/978-0-387-69080-3_21
Megan Roth, Amanda Obaidat, Bruno Hagenbuch, OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies British Journal of Pharmacology. ,vol. 165, pp. 1260- 1287 ,(2012) , 10.1111/J.1476-5381.2011.01724.X
E M Wilson, F S French, Binding properties of androgen receptors. Evidence for identical receptors in rat testis, epididymis, and prostate. Journal of Biological Chemistry. ,vol. 251, pp. 5620- 5629 ,(1976) , 10.1016/S0021-9258(17)33103-4
Gaochao Tian, J. Darren Stuart, Marcia L. Moss, Paul L. Domanico, H. Neal Bramson, Indravadan R. Patel, Sue H. Kadwell, Laurie K. Overton, Thomas A. Kost, 17 beta-(N-tert-butylcarbamoyl)-4-aza-5 alpha-androstan-1-en-3-one is an active site-directed slow time-dependent inhibitor of human steroid 5 alpha-reductase 1 Biochemistry. ,vol. 33, pp. 2291- 2296 ,(1994) , 10.1021/BI00174A041
Nima Sharifi, Akinobu Hamada, Tristan Sissung, Romano Danesi, David Venzon, Caitlin Baum, James L. Gulley, Douglas K. Price, William L. Dahut, William D. Figg, A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer. BJUI. ,vol. 102, pp. 617- 621 ,(2008) , 10.1111/J.1464-410X.2008.07629.X
Stewart L. MacLeod, Susan Nowell, Jason Plaxco, Nicholas P. Lang, An Allele-Specific Polymerase Chain Reaction Method for the Determination of the D85Y Polymorphism in the Human UDPGlucuronosyltransferase 2B15 Gene in a Case-Control Study of Prostate Cancer Annals of Surgical Oncology. ,vol. 7, pp. 777- 782 ,(2000) , 10.1007/S10434-000-0777-3
Roohollah Sharifi, Robert Browneller, , Serum testosterone suppression and potential for agonistic stimulation during chronic treatment with monthly and 3-month depot formulations of leuprolide acetate for advanced prostate cancer. The Journal of Urology. ,vol. 168, pp. 1001- 1004 ,(2002) , 10.1016/S0022-5347(05)64560-0
J Dörsam, J Altwein, 5alpha-Reductase inhibitor treatment of prostatic diseases: background and practical implications. Prostate Cancer and Prostatic Diseases. ,vol. 12, pp. 130- 136 ,(2009) , 10.1038/PCAN.2008.56
Sarah Chouinard, Mei-Fei Yueh, Robert H. Tukey, Frank Giton, Jean Fiet, Georges Pelletier, Olivier Barbier, Alain Bélanger, Inactivation by UDP-glucuronosyltransferase enzymes: the end of androgen signaling. The Journal of Steroid Biochemistry and Molecular Biology. ,vol. 109, pp. 247- 253 ,(2008) , 10.1016/J.JSBMB.2008.03.016
Hsi-Chin Wu, Jer-Tsong Hsieh, Martin E. Gleave, Nicholas M. Brown, Sen Pathak, Leland W. K. Chung, Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: Role of bone stromal cells International Journal of Cancer. ,vol. 57, pp. 406- 412 ,(1994) , 10.1002/IJC.2910570319